Related Experiment Videos
Sequential clinical and immunologic abnormalities in hemophiliacs.
Archives of Internal Medicine
|March 1, 1985
Summary
This study found that higher factor concentrate use in hemophilia patients correlated with impaired cell-mediated immunity, indicated by lower helper-suppressor ratios and increased splenomegaly. Immune function did not significantly change over time with continued concentrate use.
Area of Science:
- Immunology
- Hematology
Background:
- Hemophilia management involves factor concentrate infusions.
- Cell-mediated immunity can be affected in chronic diseases.
Purpose of the Study:
- To investigate the association between factor concentrate use and cell-mediated immunity in hemophilia patients.
- To assess changes in immune status over time.
Main Methods:
- Cross-sectional study of 35 hemophilia patients.
- Analysis of T-cell subsets, helper-suppressor ratio, and clinical signs (splenomegaly, lymphadenopathy).
- Correlation with factor concentrate use over different time intervals (1 year, 5 years, lifetime).
Main Results:
- Significant negative correlation between helper-suppressor ratio and concentrate use.
- Splenomegaly significantly associated with concentrate use.
- High prevalence of hypergammaglobulinemia, anergy, and lymphadenopathy.
- No significant changes in T-cell subsets or clinical condition during follow-up related to concentrate use.
Conclusions:
- Factor concentrate use in hemophilia is associated with markers of impaired cell-mediated immunity.
- While initial associations exist, prolonged concentrate use did not lead to significant changes in T-cell subsets or clinical status during the study period.